当前位置: X-MOL首页全球导师 海外导师 › Chamberlin, A. Richard

个人简介

Fellow, American Association for the Advancement of Science Eli Lilly Grantee UCI Physical Sciences, Distinguished Teaching Award NIH Career Development Award in neuroscience

研究领域

Chemical Biology/Organic and Synthetic

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Kaitocephalin Antagonism of Glutamate Receptors Expressed in Xenopus Oocytes Limon, A.; Reyes-Ruiz, J. M.; Vaswani, R. G.; Chamberlin, A. R.; Miledi, R. ACS Chem. Neurosci. 2010, 1, 175–181 Design, synthesis, and biological evaluation of a scaffold for iGluR ligands based on the structure of (–)-kaitocephalin Vaswani, R. G.; Limon, A.; Reyes-Ruiz, J. M.; Miledi, R.; Chamberlin, A. R. Bioorg. Med. Chem. Lett. 2009, 19, 132–135 Methods for the Chemical Synthesis of Noncoded a-Amino Acids Found in Natural Product Peptides Habay, S. A.; Park, S. S.; Kennedy, S. M.; Chamberlin, A. R., Amino Acids, Peptides and Proteins in Organic Chemistry:Vol1-Origins and Synthesis of Amino Acids, Andrew B. Hughes (ed.), Wiley-VCH, 2009, pp. 163-244. Stereoselective Synthesis of Chiral IBR2 Analogues Qiu, X. L.; Zhu, J.; Wu, G.; Lee, W. H.; Chamberlin, A. R. J. Org. Chem. 2009, 74, 2018–2027 Synthesis and Biological Evaluation of a Series of Novel Inhibitor of Nek2/Hec1 Analogues Qiu, X. L.; Li, G.; Wu, G.; Zhu, J.; Zhou, L.; Chen, P. L.; Chamberlin, A. R.; Lee, W. H. J. Med Chem. 2009, 52, 1757–1767 Synthesis and pharmacological in vitro and in vivo profile of SHA 68 (3-Oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), a selective antagonist of the Neuropeptide S receptor Okamura, N.; Habay, S. A.; Zeng, J.; Chamberlin, A. R.; Reinscheid, R. K. Journal of Pharmacology and Experimental Therapeutics, 2008, 325(3), 893-901. Activation of Protein Phosphatase 1 by a Small Molecule Designed to Bind to the Enzyme's Regulatory Site Tappan, E.; Chamberlin, A.R. Chemistry and Biology, 2008, 15, 167-174. Stereocontrolled Total Synthesis of (-)-Kaitocephalin Vaswani, R.G.; Chamberlin, A.R. J. Org. Chem., 2008, 73(5), 1661-1681. Diastereoselective Synthesis of Glutamate-Appended Oxolane Rings: Synthesis of (S)-(+)-Lycoperdic Acid. Cohen, J.L.; Chamberlin, A.R. J. Org. Chem., 2007, 72(24), 9240-9247. Synthesis of the dysiherbaine tetrahydropyran core employing a tethered aminohydroxylation reaction. Cohen, J.L.; Chamberlin, A.R. Tet. Lett., 2007, 48, 2533-2536 Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase. Charvat, T. T.; Lee, D. J.; Robinson, W. E.; Chamberlin, A. R. Bioorg. Med. Chem., 2006, 14(13), 4552-4567 Pharmacophore Identification: The Case of the Ser/Thr Protein Phosphatase Inhibitors. Colby, D.A.; Chamberlin, A.R. Mini-Reviews in Medicinal Chemistry, 2006, 6(6), 657-665. A Central Strategy for Converting Natural Products into Fluorescent Probes. Alexander, M. D.; Burkart, M. D.; Leonard, M.l S.; Portonovo, P.; Liang, B.; Ding, X.; Joullie, M. M.; Gulledge, B.M.; Aggen, J. B.; Chamberlin, A. R.; Sandler, J.; Fenical, W.; Cui, J.; Gharpure, S. J.; Polosukhin, A.; Zhang, H.; Evans, P. A.; Richardson, A. D.; Harper, M. K.; Ireland, C.M.; Vong, B. G.; Brady, T. P.; Theodorakis, E. A.; La Clair, J. J. ChemBiochem., 2006, 7(3), 409-416. Design, Synthesis and Biological Evaluation of a Scaffold for iGluR Ligands Based on the Structure of (-)-Dysiherbaine. Cohen, J.L.; Limon, A.; Miledi, R.; Chamberlin, A.R. Bioorg. Med. Chem. Lett., 2006, 16(8), 2189-2194. The substituted aspartate analogue L-B-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3. Esslinger, C. S.; Agarwal, S.; Gerdes, J.; Wilson, P. A.; Davis, E. S.; Awes, A. N.; O'Brien, E.; Mavencamp, T.; Koch, H. P.; Poulsen, D.J.; Rhoderick, J. F.; Chamberlin, A. R.; Kavanaugh, M.P.; Bridges, R. J. Neuorpharmacology, 2005, 49(6), 850-861. Fluorescent Profiling of Natural Product Producers. Sandler, J.S., Fenical, W., Gulledge, B.M., Chamberlin, A.R., La Clair, J.J. J. Am. Chem. Soc. 2005, 127, 9320-9321. Indole- and indoline-based kainate analogues with antagonist activity at ionotropic glutamate receptors. Shou, X., Miledi, R., Chamberlin, A.R. Bioorg. Med. Chem. Lett. 2005, 15, 3942-3947. Modified norcantharidins synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity. Hart, M.E., Chamberlin, A.R., Walkom, C., Sakoff, J.A., McCluskey, A. Bioorg. Med. Chem. Lett. 2004, 14, 1969-1973. Ligands for kainate subtype glutamate receptors. Shou, X., Chamberlin, A.R. Expert Opinion on Therapeutic Patents 2004, 14, 471-486. Bridging the Synthetic and Biopolymer Worlds with Peptide-Drug Conjugates Weiss, G.A.; Chamberlin, R. Chem. Biol., 2003, 10(3), 201-202. 'Linearized' and Truncated Microcystin Analogues as Inhibitors of PP1 and PP2A. Gulledge B.M., Aggen J.B., Huang H.-B., Nairn A.C., Chamberlin A.R. Bioorg. Med. Chem. Lett. 2003, 13, 2903-2906.

推荐链接
down
wechat
bug